MeSH term
Frequency | Condition_Probility | 3T3 Cells | 3 | 0.0 |
Animals | 33 | 0.0 |
Biological Transport | 2 | 0.0 |
Catalysis | 6 | 0.0 |
Cell Line | 15 | 0.0 |
Cell Membrane/physiology | 2 | 1.0 |
Comparative Study | 5 | 0.0 |
Enzyme Activation | 11 | 0.0 |
Humans | 75 | 0.0 |
Mice | 15 | 0.0 |
Mice, Knockout | 3 | 0.0 |
Mutation | 4 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 69 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 39 | 0.0 |
Signal Transduction | 10 | 0.0 |
src Homology Domains/physiology | 2 | 4.0 |
src-Family Kinases/physiology | 2 | 6.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
*Signal Transduction | 5 | 0.0 |
src-Family Kinases/*metabolism | 3 | 1.0 |
Amino Acid Sequence | 18 | 0.0 |
Binding Sites | 8 | 0.0 |
Models, Molecular | 5 | 0.0 |
Molecular Sequence Data | 19 | 0.0 |
Sequence Alignment | 4 | 0.0 |
Structure-Activity Relationship | 6 | 0.0 |
*src Homology Domains | 4 | 2.0 |
Ligands | 3 | 0.0 |
Peptide Fragments/chemistry/metabolism | 2 | 1.0 |
Protein Structure, Secondary | 3 | 0.0 |
Protein Structure, Tertiary | 10 | 0.0 |
Protein-Tyrosine Kinase/*chemistry/*metabolism | 2 | 13.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Naphthalenes/pharmacology | 2 | 2.0 |
Protein-Tyrosine Kinase/metabolism | 2 | 0.0 |
Rats | 6 | 0.0 |
Rats, Wistar | 2 | 0.0 |
Signal Transduction/*physiology | 2 | 0.0 |
src-Family Kinases/metabolism | 6 | 3.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Tumor Cells, Cultured | 12 | 0.0 |
Blotting, Western | 7 | 0.0 |
Breast Neoplasms/*enzymology | 2 | 3.0 |
Cell Division | 3 | 0.0 |
Cell Transformation, Neoplastic | 2 | 0.0 |
Down-Regulation | 2 | 0.0 |
Mitosis | 2 | 0.0 |
Neoplasm Invasiveness | 2 | 0.0 |
Phosphorylation | 34 | 0.0 |
Recombinant Proteins/metabolism | 5 | 0.0 |
Time Factors | 3 | 0.0 |
Transfection | 11 | 0.0 |
Aged | 4 | 0.0 |
Blotting, Northern | 3 | 0.0 |
Female | 6 | 0.0 |
Male | 6 | 0.0 |
Middle Aged | 4 | 0.0 |
Protein-Tyrosine Kinase/genetics/*metabolism | 3 | 2.0 |
Proto-Oncogene Protein pp60(c-src)/genetics/*metabolism | 3 | 27.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Cells, Cultured | 6 | 0.0 |
Jurkat Cells | 9 | 0.0 |
Lymphocyte Activation/*physiology | 2 | 2.0 |
Models, Biological | 2 | 0.0 |
Muromonab-CD3/pharmacology | 2 | 2.0 |
Phosphotyrosine/metabolism | 2 | 0.0 |
Vanadates/pharmacology | 2 | 1.0 |
src Homology Domains | 9 | 1.0 |
Chromosome Mapping | 3 | 0.0 |
Cyclic AMP-Dependent Protein Kinases/*metabolism | 2 | 2.0 |
*Lymphocyte Activation | 3 | 0.0 |
Lymphocyte Specific Protein Tyrosine Kinase p56(lck)/metabolism | 3 | 5.0 |
Protein-Tyrosine Kinase/*metabolism | 10 | 1.0 |
T-Lymphocytes/*immunology | 3 | 0.0 |
Binding Sites/genetics | 2 | 0.0 |
COS Cells | 6 | 0.0 |
Conserved Sequence | 2 | 0.0 |
Macromolecular Substances | 2 | 0.0 |
Protein-Tyrosine Kinase/*chemistry/genetics/*metabolism | 2 | 11.0 |
Sequence Homology, Amino Acid | 8 | 0.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
Tyrosine/chemistry | 4 | 3.0 |
Protein-Tyrosine Kinase/*genetics/metabolism | 2 | 4.0 |
Receptors, Antigen, T-Cell/*metabolism | 3 | 2.0 |
Signal Transduction/physiology | 2 | 0.0 |
Antigens, CD3/metabolism | 2 | 1.0 |
Cloning, Molecular | 4 | 0.0 |
Protein Binding | 12 | 0.0 |
Amino Acid Substitution | 2 | 0.0 |
Enzyme Induction | 2 | 0.0 |
Mutagenesis, Site-Directed | 6 | 0.0 |
Protein Conformation | 5 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
*Mitogen-Activated Protein Kinases | 2 | 0.0 |
Protein-Tyrosine-Phosphatase/metabolism | 2 | 1.0 |
Point Mutation | 3 | 0.0 |
*src Homology Domains/genetics | 2 | 33.0 |
src-Family Kinases/*antagonists & inhibitors | 2 | 12.0 |
Protein-Tyrosine Kinase/*genetics | 5 | 2.0 |
Cell Adhesion | 3 | 0.0 |
Protein-Tyrosine Kinase/*physiology | 2 | 1.0 |
Tyrosine/*metabolism | 5 | 1.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/*metabolism | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
Tyrosine/metabolism | 5 | 0.0 |
Receptor, Insulin/metabolism | 2 | 2.0 |
Proto-Oncogene Protein pp60(c-src)/metabolism | 2 | 5.0 |
Catalytic Domain | 2 | 0.0 |
Crystallography, X-Ray | 3 | 0.0 |
Protein-Tyrosine Kinase/*chemistry/metabolism | 2 | 16.0 |
src-Family Kinases/*genetics | 2 | 40.0 |
Tetradecanoylphorbol Acetate/pharmacology | 2 | 0.0 |
Phosphotransferases/metabolism | 2 | 4.0 |
Kinetics | 8 | 0.0 |
Megakaryocytes | 2 | 18.0 |
Protein-Tyrosine Kinase/biosynthesis/*metabolism | 2 | 18.0 |
*Proto-Oncogene Protein pp60(c-src) | 11 | 61.0 |
Sequence Deletion | 4 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Receptor, erbB-2/*metabolism | 2 | 1.0 |
Immunoblotting | 2 | 0.0 |
Blood Platelets/*enzymology | 2 | 2.0 |
Cytoskeleton/metabolism | 2 | 0.0 |
Protein-Tyrosine Kinase/immunology/*metabolism | 2 | 10.0 |
Thrombin/*pharmacology | 2 | 1.0 |
Hela Cells | 3 | 0.0 |
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 3 | 1.0 |
Mutagenesis | 2 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Protein-Tyrosine-Phosphatase/genetics/*metabolism | 2 | 4.0 |
T-Lymphocytes/*enzymology | 2 | 3.0 |
Proto-Oncogene Protein pp60(c-src)/*metabolism | 5 | 12.0 |
Membrane Proteins/*physiology | 2 | 1.0 |
Spodoptera | 2 | 0.0 |
Protein-Tyrosine Kinase/*antagonists & inhibitors | 2 | 1.0 |
Substrate Specificity | 6 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 2 | 0.0 |
Cytoskeletal Proteins/metabolism | 2 | 0.0 |
Phosphoproteins/metabolism | 2 | 0.0 |
Base Sequence | 5 | 0.0 |
DNA Primers | 2 | 0.0 |
Phosphoproteins/*metabolism | 2 | 0.0 |
Cell Movement | 2 | 0.0 |
Protein-Tyrosine Kinase/*chemistry/genetics/metabolism | 2 | 25.0 |
Proto-Oncogene Proteins c-abl/metabolism | 2 | 10.0 |
Alanine/chemistry | 2 | 2.0 |
Peptides/chemistry | 3 | 0.0 |
Protein-Tyrosine Kinase/*chemistry | 2 | 10.0 |
Plasmids/metabolism | 2 | 0.0 |
Protein-Tyrosine Kinase/chemistry/*metabolism | 2 | 5.0 |
DNA/metabolism | 2 | 0.0 |
Precipitin Tests | 2 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
Membrane Microdomains/*metabolism | 2 | 4.0 |
